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The Microsporidia are a ubiquitous group of eukaryotic obligate intracellular parasites which were recognized over 100 years ago
with the description of Nosema bombycis, a parasite of silkworms. It is now appreciated that these organisms are related to the
Fungi. Microsporidia infect all major animal groups most often as gastrointestinal pathogens; however they have been reported
from every tissue and organ, and their spores are common in environmental sources such as ditch water. Several diﬀerent genera of
these organisms infect humans, but the majority of infections are due to either Enterocytozoon bieneusi or Encephalitozoon species.
These pathogens can be diﬃcult to diagnose, but signiﬁcant progress has been made in the last decade in the development of
molecular diagnostic reagents for these organisms. This report reviews the molecular diagnostic tests that have been described for
the identiﬁcation of the microsporidia that infect humans.
Copyright © 2009 K. Ghosh and L. M. Weiss. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
The Microsporidia are a phylum of over 1200 species
representing at least 150 genera [1, 2]. Since the mid-
1980s, these organisms have increasingly been implicated
as agents of human disease, especially in their capacity
as opportunistic pathogens in patients with HIV infection
[2, 3] and other immunosuppressed individuals, such as
thosewithorgantransplantationorchemotherapyrecipients
[4]. To date, fourteen species in eight genera have been
found to infect humans [5]. In HIV-positive patients, the
most common clinical manifestation is chronic diarrhea
and wasting due to enteric infection, but the spectrum of
disease due to these pathogens is broad and includes hep-
atitis, peritonitis, keratoconjunctivits, sinusitis, bronchitis,
pneumonia, cystitis, nephritis, myositis, encephalitis, and
other cerebral infections [4]. In addition, microsporidia have
also been reported to be etiologic in isolated case reports of
urethritis,prostaticabscess,tongueulcer,boneinfection,and
cutaneous infection [4]. There is an increasing appreciation
that these organisms can also cause gastrointestinal and ocu-
lar infections in apparently immunocompetent individuals.
Serosurveys [6, 7] suggest that microsporidiosis is common,
but usually self-limiting or asymptomatic in the general
population. While transmission routes have not been speciﬁ-
cally documented in epidemiologic studies, there is evidence
that infections can occur by multiple routes (enumerated
in [2]) including waterborne, respiratory, sexual, congenital,
zoonotic transmission, and in ocular infection by traumatic
inoculation into the cornea.
All microsporidia produce an environmentally resistant
spore which is capable of extruding its coiled, internal polar
ﬁlament (i.e., polar tube) thereby inoculating its contents
into a nearby host cell. Unique in structure and function,
identiﬁcation of the polar ﬁlament is diagnostic for the
phylum. Due to the small size of the organisms, for example,
several of the human-infecting species measure 1–2µm
[4], diagnosis of microsporidiosis has traditionally relied
on transmission electron microscopy (TEM) to identify
the polar ﬁlament and other phylum- and species-speciﬁc
ultrastructuralcharacters.Althoughit remains thegoldstan-
dard, TEM is labor-intensive and time-consuming, requiring
expensive equipment, signiﬁcant specialized expertise, and
a dedicated histological staﬀ working over the course of
several days. It is also relatively insensitive, due to the small
amount of tissue that can be examined and the lack of signal2 Interdisciplinary Perspectives on Infectious Diseases
ampliﬁcation. Light microscopy-based methods have also
been developed and are faster and typically more sensitive
than TEM, but they still require experienced pathologists for
successfulinterpretation.Thesemethodsincluderoutinehis-
tological stains such as the modiﬁed trichrome stain which
is used alone or in combination with other stains such as
Gram or Warthin-Starry silver [1]. Although these methods
are more convenient than TEM for detecting microsporidia
in body ﬂuids and tissues, the internal polar ﬁlament is not
easily identiﬁed using these techniques. Rather, diagnosis
hinges mostly on the detection of the thick spore wall which
is birefringent and provides selective staining characteris-
tics with the modiﬁed trichrome stain. Chemoﬂuorescent
brighteners (e.g., Calcoﬂuor White, Uvitex 2B, Fungiﬂuor)
have been used to target the chitin within the spore wall.
While sensitive, the potential for cross reactivity with Fungi
and artifactual material exists, especially in stool specimens.
Thus, it has been recommended that chemoﬂuorescent
brighteners should be used in combination with traditional
histologicalstains,toprovidebettersensitivityandspeciﬁcity
when examining stool specimens. However, even the best
possible tissue preparation and staining for light microscopy
rarely enables a microsporidian species-speciﬁc diagnosis.
This is a critical shortcoming in light of the need for diﬀerent
treatments for the various microsporidian species that infect
humans [8].
While TEM evidence of the polar ﬁlament or other
ultrastructural features unique to the phylum is considered
incontrovertible proof of microsporidiosis, a more speciﬁc
diagnosis is not always possible on the basis of morphology
alone. Especially in the case of closely related species,
distinguishing characteristics may arise in only certain
developmental stages of the organism, all of which may
not be present in a particular clinical sample. While in
vitro culture is conceivable as a tool to aid in diagnosis
for several human-infecting species, culture methods are
laborious, subjecttocontamination, andusuallyimpractical;
moreover, for Enterocytozoon bieneusi, the most common
microsporidiumfoundinhumans,noinvitroculturesystem
exists [9]. Thus, there exists a need for faster, more speciﬁc,
and more accessible approaches to diagnosis in both clinical
specimens and environmental samples.
Over the past decade or so, molecular biology-based
procedureshavebeenincreasinglyusedinclinicalsettingsfor
the diagnosis and characterization of microbial pathogens.
These procedures are designed to detect either a nucleic acid
sequence or antigen speciﬁc to the pathogen. Compared to
traditional microscopy- or culture-based methods, molec-
ular methods can oﬀer the following potential advantages:
increased sensitivity, by virtue of ampliﬁcation of signal;
greater speciﬁcity, when appropriate detection probes are
employed; faster time-to-result; and greater ease of inter-
pretation by nonspecialists [10]. While clinical laboratories
still primarily rely on microscopy-based methods for the
diagnosis of microsporidia, over the past ﬁfteen years
signiﬁcant eﬀort has been directed to the development of
molecular methods in research laboratories. This article will
review the progress toward molecular diagnostics of these
emerging pathogens.
2.NucleicAcid-BasedDetection Methods
Nucleic acid-based detection methods utilize synthetic DNA
molecules that are speciﬁc and complementary to a sequence
in the DNA of the pathogen. The earliest methods employed
labeled probes which hybridized to pathogen DNA and
emitted a detectable (e.g., ﬂuorescent) signal. Such DNA
probe technologies are still in use today, although they have
been largely supplanted by methods that amplify the target
sequence; of these methods the most commonly utilized
is the polymerase chain reaction (PCR) (for a historical
perspective, see [11]). In PCR, the target pathogen DNA is
bound by a speciﬁcally designed set of primers and copied
over and over again in the presence of free nucleotides
by a themostable polymerase enzyme. The ampliﬁcation
of the target pathogen DNA (i.e., amplicon) confers two
advantages: improved detection sensitivity relative to probe-
based methods and facilitation of downstream analyses (e.g.,
restriction analysis, sequencing) of the amplicon.
Techniques for sample preparation for the molecular
diagnosis of microsporidia have been reviewed in detail
in Weiss and Vossbrinck [12]. The technique used to
extract DNA for ampliﬁcation can signiﬁcantly aﬀect the
sensitivity of a PCR diagnostic technique. Nucleic acids
may be extracted from clinical samples such as tissue
biopsies, corneal scrapings, duodenal aspirations, and urine
s p e c i m e n sa sw e l la si nv i t r oc u l t u r e sw i t hc o m m e r c i a lD N A
extraction kits (e.g., those manufactured by Qiagen, Santa
Clara, Calif, Usa, or Promega, Madison, Wis, Usa) or by
routine procedures such as proteinase K digestion followed
by phenol-chloroform extraction and ethanol precipitation
[13]. DNA may also be isolated from paraﬃn-embedded
material by standard methods [14] or with commercial
kits such as DexPAT (Takera Biochemical, Berkeley Calif,
Usa). DNA has been successfully ampliﬁed from modiﬁed
trichrome-stained[15]anddecades-oldGiemsa-stained[16]
microscope slides by scraping the material oﬀ of the slides
followed by mechanical disruption of the microsporidia
(using glass beads) and subsequent DNA extraction using
standard techniques.
The isolation and ampliﬁcation of DNA from stool
samples is more challenging, generally requiring mechanical
disruption and/or harsh extraction conditions. Success-
ful reported methods include subjection to 0.5% sodium
hypochlorite [17], chitinase [17], lyticase [18], guanidine
thiocyanate [19–21], 10% formalin or M potassium hydrox-
ide [17, 22, 23], dithiothreitol [22], hexadecyltrimethylam-
moniuim bromide [24], or boiling the samples (Ombrouck
et al. [25] . Stool samples frequently contain inhibitors
of polymerase enzymes [26]. If they are not removed by
the above methods, dilution of the samples (Ombrouck et
al.,[27]) or guanidine thiocyanate treatment [19]m a yb e
warranted. An extraction-free template preparation method
for stool samples has also been developed [28] using FTA
ﬁlters impregnated with denaturants, chelating agents, and
free-radical traps, which apparently causes most cells to lyse
on contact and enables debris and other inhibitory factors
to be washed away from the DNA trapped on the ﬁlter. In
one study this FTA ﬁlter method allowed the detection ofInterdisciplinary Perspectives on Infectious Diseases 3
800 microsporidian spores per milliliter of stool by a PCR
technique (Subrungruang et al., [29]) .
In order to apply PCR-based diagnostics to a pathogen,
some genetic sequence information must be known in
advance. The human-infecting microsporidia are a diverse
group of “emerging” pathogens, and the available genetic
information on these organisms is limited but ever-
increasing. For the majority of the microsporidia GenBank
sequence data on their rRNA genes is the only genetic
information available. The number of microsporidian genes
deposited in GenBank has grown from less than 200 in 1999
(surveyed in [12]) to almost 6000 today. Approximately two-
thousandofthesearethegenomesequence-relatedpredicted
genes proposed by Katinka et al. [30] in their landmark
genomic sequencing of the human pathogen Encephalitzoon
cuniculi, the ﬁrst and to-date only microsporidium genome
to be completely sequenced. For the closely related species
Encephalitozoon hellem, there are 75 entries. Recently, a
genomic survey of the essentially noncultivatable pathogen
Enterocytozoon bieneusi resulted in the addition of another
three-thousand hypothetical genes, some of which are
homologs to the genes identiﬁed in Enc. cuniculi [31]. For
the other eleven human-infecting species of microsporidia,
between zero and a few dozen genes have been deposited in
GenBank.
Due to the availability of sequence information as
well as the presence of conserved and variable regions
within the rRNA genes, PCR-based methods have typically
utilized primers to this gene for the characterization of
the microsporidia. The ﬁrst such report of the use of
conserved rRNA primers was of that of the cloning of
the small subunit (SSU) rDNA of Vairimorpha necatrix,a
pathogen of agricultural pests [32]. Primers complementary
to conserved sequences within this gene were used to amplify
and subsequently obtain sequence data on the rRNA gene
of several human-infecting microsporidia, including Enc.
cuniculi, Enc. hellem, Enc. intestinalis, Ent. bieneusi,a n d
Vittaforma corneae (reviewed in [33, 34]). These rRNA
genes have been reported by Katinka et al. [30]t ob ep r e s e n t
in more than twenty copies in the Enc. cuniculi genome, and
therefore, provide an increase in sensitivity (over single copy
genes) for use in diagnostic PCR tests.
Diagnostic studies using primers to the various rRNA
genes of microsporidia have been reviewed by Weiss
and Vossbrinck [12] and Franzen and Muller [35]. The
sequences of many of the primer pairs used for the
ampliﬁcation of various microsporidia, along with the
recommended annealing temperatures for PCR and the
expected amplicon size, are compiled in Table 1 (adapted
from [12]). Some of these primers are species-speciﬁc
whereas others are more general primer sets that amplify all
of the Encephalitozoonidae. For some of these primer sets
downstream restriction analysis, wherein the amplicon is
digested into smaller pieces by speciﬁc restriction enzymes,
is required for species speciﬁc diagnoses.
PCR has also been useful for the identiﬁcation of
the previously unknown microsporidia in human and
veterinary infections. Using phylogenetically conserved
primers amplifying the small subunit (SSU), large subunit
(LSU), and intergenic spacer (IGS) regions, it has been
possible to clone and then sequence portions of the
rRNA gene of uncharacterized microsporidia from biopsy
specimens (Table 2,a d a p t e df r o m[ 12]). These rRNA
sequence data can then be used for phylogenetic analysis
using BLAST and similar in silico programs comparing
the unknown sequence to the rRNA sequences on various
microsporidia available in GenBank. The primers in Table 2
form the basis of a “molecular toolbox” which allows
the cloning of rRNA genes from novel species or strains
of microsporidia. The primer pairs V1(18f)::1492r and
530f::580r are considered “universal” in that they are usually
successful in amplifying unknown rRNA genes for novel
species or strains of microsporidia ([36], also see [12]).
Several investigators have published diagnostic
procedures for microsporidia which use real-time PCR
[33, 34, 53, 54, 56]. Real-time PCR, which detects
accumulating amplicons in real time via interacting
either ﬂuorescent dyes or ﬂuorescence-labelled probes, has
the advantage of being quantitative over a broad dynamic
range. In addition, it typically employs a multiwell format
and dispenses with postampliﬁcation processing of the
sample, which increases throughput and reduces the risk
of contamination inherent in PCR [57]. Hester et al. [53]
used a probe speciﬁc for the small subunit rRNA of the
genus Encephalitozoon and species-speciﬁc primers for Enc.
cuniculi, Enc. hellem, and Enc. intestinalis. While their
method was validated only for puriﬁed microsporidian
DNA, it could be adapted for clinical samples. Another
study utilized pan-Encephalitozoon primers speciﬁc to small
subunit rRNA and a guanidine thiocyanate-based extraction
system designed for an automated workstation to detect
Enc. cuniculi, Enc. hellem,a n d Enc. intestinalis from stool
specimens [56]. The assay was sensitive (detection limit
between 102 to 103 spores/mL) and reﬂective of infection
intensity (linear range was between 103 and 107 spores/mL).
In addition, melting curve analyses of the amplicons readily
allowed diﬀerentiation of the three Enc.s p e c i e s . ,w h i c h
is useful for multiple or unknown infections. In 2003, a
real-time PCR assay using primers for Enc. intestinalis small
subunit rRNA was used to detect this pathogen from known
clinical samples, including stools, urine, tissue biopsies,
bronchopulmonary specimens, and blood [33, 34]. Using
control reference spores, the detection limit was estimated
to be 20 spores per milliliter, which was suﬃcient to detect
a relatively low-intensity blood infection suggesting that an
infection was disseminated [33, 34]. Finally, a multiplex real-
time PCR assay has also been reported to simultaneously
detect Ent. bieneusi, Enc. cuniculi, Enc. hellem,a n dEnc.
intestinalis from both fresh and formalin-ﬁxed stool with
primers for the intergenic region and small subunit rRNA of
Ent. bieneusi and Encephalitozoon species., respectively [54].
Ent. bieneusi was detected in 30 of 33 known microsporidia-
positive samples. The study included a range of negative
and positive controls to verify the assay speciﬁcity and guard
against false negatives due to inhibitors potentially present
in stool or to the presence of extraneous DNA, respectively.
A few studies have also utilized ﬂuorescent in situ hybr-
idization (FISH-) based methods to detect microsporidia.4 Interdisciplinary Perspectives on Infectious Diseases
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Table 2: Primers for the identiﬁcation and sequencing of micro-
sporidian rRNA1 Genes.
ss218f
3 CACCAGGTTGATTCTGCC
ss18sf GTTGATTCTGCCTGACGT
ss350f CCAAGGA(T/C)GGCAGCAGGCGCGAAA
ss350r TTTCGCGCCTGCTGCC(G/A)TCCTTG
ss530f GTGCCAGC(C/A)GCCGCGG
ss530r CCGCGG(T/G)GCTGGCAC
ss1047r AACGGCCATGCACCAC
ss1061f GGTGGTGCATGGCCG
ss1492r GGTTACCTTGTTACGACTT (Universal primer)
ss1537 TTATGATCCTGCTAATGGTTC
ls212r1 GTT(G/A)GTTTCTTTTCCTC
ls212r2 AATCC(G/A/T/C)(G/A)GTT(G/A)GTTTCTTTTCCTC
ls580r GGTCCGTGTTTCAAGACGG
1- Primers 18f and 1492r amplify most of the small subunit rRNA of the
microsporidia. Primes 530f and 212r1 or 212r2 are used to amplify the
small subunit rRNA and the ITS region. The remaining primers are used to
sequence, with overlap, the forward and reverse strands of the entire small
subunit rRNA and ITS region. ls580r ampliﬁes a variable region of the 5 
end of the large subunit rRNA gene of many microsporidia (e.g.,N o s e m a
and Vairimorpha) but it does not work on all microsporidia. ss1537 allows
sequencing closer to the 3  end of the small subunit rRNA of many but
not all microsporidia. ss350f and ss350r may not be needed for sequencing
reactions if 18f and 530r provide suﬃcient overlap to obtain clear sequence
data.
2- ss: denotes primers in the small subunit rRNA gene,
ls: denotes primers in the large subunit rRNA gene,
f: forward primer (positive strand),
r: reverse primer (negative strand).
3- Similar to V1 primer.
Adapted from [12].
Essentially, FISH technology utilizes a ﬂuorescence-labeled
probe that binds to complementary nucleic acid (DNA or
RNA)in the specimen[10]. In contrastto PCR, general mor-
phological and spatial information regarding probe-binding
in the specimen may be retained because the procedure is
performed in situ. FISH has been used with probes against
the small subunit or intergenic regions of microsporidia
rRNA to detect Ent. bieneusi and Enc. hellem [24, 51,
52]. These methods were used successfully with archived
formalin-ﬁxed, paraﬃn-embedded (FFPE) clinical samples
and detected either more microsporidia-positive samples or
more infected cells within samples than traditional histo-
chemical staining. In the case of Ent. bieneusi, characteristic
staining of parasites in a supranuclear location within jejunal
biopsy epithelial cells [24] and staining of developmen-
tal forms [52] contributed to the certainty of diagnosis.
Although FISH is an attractive procedure due to the
multifacetedinformation,itcanprovidetwofactorsseriously
hamper its potential for general use in clinical diagnostic set-
tings. Firstly, it is rather laborious and technically challeng-
ing, requiring deparaﬃnization, dehydration, and rehydra-
tion (of FFPE samples), digestion by proteinases to make the
nucleic acid accessible to the probe, labeling and overnight
hybridization of the probe, blocking, counterstaining, and
many wash steps prior to viewing with an epiﬂuorescence-
equipped microscope. Secondly, it is less sensitive than PCR
by orders of magnitude due to the lack of ampliﬁcation of
original signal (i.e., the nucleic acid target). Nonetheless,
it may prove particularly useful for environmental samples
wherein discrimination of live versus dead organisms is
important,whichcanbeaﬀordedbydesigningprobesforthe
less-stable RNA rather than DNA (discussed in [51]).
Of interest is the report of the development of an
oligonucleotide microarray to simultaneously detect Ent.
bieneusi, Enc. cuniculi, Enc. hellem,a n dEnc. intestinalis
from clinical samples [55]. Such microarrays were originally
developed for genomewide expression analysis but have
recently been applied to molecular diagnostics [10, 58].
Microarray technology commonly employs an array of
target-complementary oligonucleotides printed on a “chip”
to which ﬂuorescence-labelled nucleic acid from the sample
is hybridized; the degree of ﬂuorescence correlates to the
abundance of the sample DNA. Because of the array format
and the analog nature of ﬂuorescence intensity, this tech-
nology is intrinsically high-throughput and somewhat quan-
titative, respectively. Wang et al. [55] capitalized on these
advantages and combined them with the sensitivity of PCR
by ﬁrst using conserved, family-speciﬁc primers to amplify
1.3-kb microsporidia rRNA fragments from unextracted,
FTA-ﬁltered clinical fecal samples before hybridization to
a microsporidia microarray. Multiple speciﬁc probes were
then used to confer genus- and species-level hybridization
proﬁles to the assay and to increase sensitivity by decreasing
amplicon size (i.e., in a “nested” fashion). The array was able
to simultaneously detect all four species of microsporidia
at a sensitivity of 102 spores per 100 µLo ff e c a ls a m -
ple. In a survey of 20 fecal samples from AIDS patients
suﬀering from diarrhea of unknown etiology, 12 samples
were microsporidia-positive, and all but one were apparently
multiply-infected. No masking eﬀect by the more abundant
species was evident, and the probe hybridization proﬁle
for each species oﬀers a tentative assessment of infection
intensity. The printing of four individual microarrays per
slide increases the potential throughput of this technique.
3.Antigen-BasedDetectionMethods
Antigen-based detection methods such as the immunoﬂu-
orescence assays (IFAs), ELISA, and immunoblot use anti-
bodies from experimentally immunized animals to recognize
characteristic pathogen speciﬁc antigens. IFA can be used
in situ on ﬁxed specimens but needs to be examined
using ﬂuorescence microscopy. Immunoblot or ELISA tests
examine an homogenate of the specimen. Antibodies may
be either polyclonal (i.e., puriﬁed from animal sera and
directed against various epitopes of the protein, and possibly
containing other, nonspeciﬁc antibodies which can increase
background signal) or monoclonal (puriﬁed from cell cul-
ture supernatants).
A number of monoclonal and polyclonal antibod-
ies against human-infecting microsporidia including Ent.
bieneusi, Enc. cuniculi, Enc. hellem,a n dEnc. intestinalis have
been developed [59–65]. Most often these antibodies have
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Microsporidia. Some of these antibodies have demonstrated
cross-reactivity among various species of microsporidia by
IFA or immunoblot. While some investigators have reported
IFA tests that had an equal sensitivity to a reference PCR
(e.g.,[64]),themajorityofinvestigatorsbelievethatIFAtests
are less sensitive than PCR based methods. In any case, the
speciﬁcity and sensitivity depend to a great extent on the
antibody itself and the care with which the various steps
(e.g. ﬁxation, blocking, and washes) are executed. Antibody-
based detection is best used as a supplement to conventional
histological techniques, and in diﬃcult cases nucleotide-
based detection should be utilized as well.
4.Antibody-BasedDetectionMethods
Serologic tests such as the enzyme-linked immunosorbent
assay (ELISA), immunoblot, and agglutination-based tests
[66, 67] which can detect circulating antibody are not
currently recommended for diagnostic purposes due to
variable expression of antibodies in immunocompromised
patients, the inability to discriminate between acute and past
infections [68], the high prevalence of anti-microsporidian
antibodies in apparently healthy, immunocompetent pop-
ulations [6, 7], and cross-reactivity of antibodies between
diﬀerent species. However, these serologic analyses may
be useful to diagnose subclinical infections in prospective
transplant donors or patients who may be at risk for reac-
tivation of infection due to impending immune compromise
(discussed in [8]).
5. Detection of Microsporidia from Environ-
mental Samples
Because many species of microsporidia are enteric pathogens
in humans and animals and are transmitted as envi-
ronmentally resistant spores [69], it is likely that water-
borne transmission of these parasites occurs. Human-
pathogenic microsporidia have been detected in surface
water, groundwater, and tertiary agricultural eﬄuent [23,
70–75], which poses a contamination risk to drinking,
recreational, and agricultural water supplies. Indeed, in 1999
there was a conﬁrmed waterborne outbreak of microsporid-
iosisthataﬀectedbothimmune-compromisedandimmune-
competent individuals [76] .A sar e s u l to fs u c hs t u d i e s ,
the U.S. Environmental Protection Agency included the
microsporidia on its two most recent Candidate Contami-
nant Lists (CCL-1 and -2) in 1998 and 2005, respectively.
The CCL-2 currently consists of eight other candidate
microbiological agents and 42 chemical agents which are
known or anticipated to be present in public water systems
and which may require regulation under the Safe Drinking
Water Act.
Waterborne protozoa are usually detected from large-
volume water samples by ﬁlter-based or centrifugal concen-
tration followed by puriﬁcation and molecular or micro-
scopic identiﬁcation of the organism from the concentrated
material [77]. Currently, methods for the enrichment of
microsporidia in water samples have not been standardized,
but relatively expedient concentration of spores has been
achieved by continuous ﬂow centrifugation (CFC) [78]o r
continuous separation channel centrifugation [79]. In the
case of water samples, puriﬁcation of spores by immuno-
magnetic separation (IMS), which utilizes pathogen-speciﬁc
antibody-coated beads prior to detection by real-time PCR,
was shown to be 78%–90% sensitive for seeded spores in
ultrapure water [78], although the paucity of commercially
available anti-microsporidia antibodies currently limits the
accessibility of this approach. In all cases requiring detection
ofmicrosporidiafromturbidsamplessuchasfeces-impacted
or otherwise turbid environmental water, the small size of
human-pathogenic microsporidia impedes detection sensi-
tivity, as it necessitates a reduction in ﬁlter pore size which
increases membrane-fouling, thus eﬀectively decreasing the
volume of water that can be ﬁltered [78]. In the case of
feces or heavily feces-impacted wastewater, a similar problem
arises in that although smaller, ﬁltered, or unﬁltered volumes
maybeanalyzedforthesakeofconvenience,andtominimize
the eﬀect of PCR inhibitors usually present therein [26],
such small volumes may not be representative of the entire
sample or may be inadequate for detection of low-intensity
contaminations (discussed in [80]). Nonetheless, detection
limits of 102 to 103 spores per milliliter of feces or wastewater
were achieved by sucrose-ﬂotation puriﬁcation followed by
DNA extraction using commercial kits and PCR [80], a
signiﬁcant improvement over previously reported methods
even for less turbid samples [71, 81].
While waterborne microsporidia likely pose the greater
environmental threat, nonaquatic dispersal of microsporidia
is also a public health concern. Spores have been identiﬁed
on fresh produce in Poland such as berries and other
fruits, sprouts, and green-leaf vegetables [82] ,p e r h a p sa sa
consequenceofmicrosporidialcontaminationofagricultural
irrigation waters [74] or sewage-sludge end products used
as fertilizer [83, 84]. Three species of Encephalitozoonidae
were detected by FISH at levels likely to be infective for
humans. In urban settings in Europe and North America,
human-infecting microsporidia have been identiﬁed from
pigeon fecal droppings [83–86]. The genotype of one isolate
was found to match that of a previously reported human-
infecting isolate [86], and in one study, 11% of pigeon fecal
sampleswerefoundtobeEnt.bieneusi-positive[85].Graczyk
et al. [83, 84] estimated that a person could inhale 103 viable,
aerosolized spores in 30 minutes of occupational or inci-
dental exposure to heavily pigeon excrement-contaminated
surfaces. In addition, Mathis et al. [87] demonstrated Ent.
bieneusi in feces of farm dogs and cats; diagnostic PCR
suggested that the strains are closely related to human
isolates. These ﬁndings support the notion that human
microsporidiosis is a zoonotic disease [69, 88, 89]a n d
highlight the utility of molecular methods to identify new
sources of risk to human health.
6. Conclusion
The potential of molecular diagnostics and particularly
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in terms of sensitivity, speciﬁcity, speed, and reproducibility
has already achieved proof-of-concept for other pathogens
[10, 11]. Indeed, this has been demonstrated for the
microsporidia in molecular detection studies that processed
corresponding specimens for light microscopy (e.g., [24,
51]).Althoughablinded,multicenterevaluationofdetection
methods for the microsporidia conducted in 1998 (Rinder et
al. [90]) revealed only a modest sensitivity advantage of PCR
(89%) over light microscopy (80%), the greatest diﬀerences
were seen between individual laboratories. Thus it is likely
that as the molecular diagnostic methods are perfected over
time and clinical diagnostic technicians become accustomed
to them, their advantages will become more apparent. While
the costs of such technology and requisite training of staﬀ
mayseeminitiallyprohibitive,theembeddedcostsofdelayed
and nonspeciﬁc or incorrect diagnosis to both patients and
health care systems should be considered (see [11]).
In summary, molecular detection methods for the
microsporidia described herein are potentially more sen-
sitive, speciﬁc, and depend less on the subjectivity of
the observer than traditional microscopy-based methods.
Additionally, sophisticated nucleotide-based methods such
as real-time PCR and oligonucleotide microarrays are
intrinsically higher-throughput and quantitative, enabling
simultaneousanalysisofspecimensformultiplepathogensas
well as a tentative assessment of infection intensity. Although
the time-to-result and reproducibility in clinical diagnostic
settings have yet to be evaluated, a modest learning curve
should be expected considering the “emerging” nature of
these pathogens (see [91]). Looking ahead as more physi-
ological insight into these pathogens is aﬀorded by recent
genomic sequencing projects [30, 31], these technologies
may even be adapted as necessary to applications such as
strain-genotyping and drug sensitivity-proﬁling.
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